Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS)

CUSIP: 87184Q107

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
27,995,500
Total 13F shares
22,234,612
Share change
+549,601
Total reported value
$123,844,000
Price per share
$5.57
Number of holders
67
Value change
+$995,029
Number of buys
30
Number of sells
36

Quarterly Holders Quick Answers

What is CUSIP 87184Q107?
CUSIP 87184Q107 identifies SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
18%
5,048,158
$60,124,000 30 Sep 2018
13F
ARK Investment Management LLC
13F
Company
7.9%
2,221,870
$26,462,000 30 Sep 2018
13F
Redmile Group, LLC
13F
Company
5.9%
1,656,138
$19,725,000 30 Sep 2018
13F
BlackRock Finance, Inc.
13F
Company
5.8%
1,613,668
$19,219,000 30 Sep 2018
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
4.5%
1,268,945
$15,113,000 30 Sep 2018
13F
VANGUARD GROUP INC
13F
Company
3.7%
1,044,939
$12,446,000 30 Sep 2018
13F
BAKER BROS. ADVISORS LP
13F
Company
2.1%
574,835
$6,846,000 30 Sep 2018
13F
STATE STREET CORP
13F
Company
1.4%
381,882
$4,550,000 30 Sep 2018
13F
JPMORGAN CHASE & CO
13F
Company
1.3%
369,959
$4,406,000 30 Sep 2018
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
1.2%
327,214
$3,897,000 30 Sep 2018
13F
NORTHERN TRUST CORP
13F
Company
1.1%
303,988
$3,620,000 30 Sep 2018
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.81%
226,434
$2,696,000 30 Sep 2018
13F
S.c.a. Candriam
13F
Individual
0.73%
204,000
$2,430,000 30 Sep 2018
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.62%
172,846
$2,059,000 30 Sep 2018
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.54%
150,352
$1,791,000 30 Sep 2018
13F
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
0.54%
150,000
$1,787,000 30 Sep 2018
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.46%
129,057
$1,538,000 30 Sep 2018
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.42%
118,661
$1,413,000 30 Sep 2018
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.34%
94,206
$1,122,000 30 Sep 2018
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.31%
85,900
$1,023,000 30 Sep 2018
13F
Point72 Asset Management, L.P.
13F
Company
0.29%
81,838
$975,000 30 Sep 2018
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.29%
81,377
$969,000 30 Sep 2018
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.28%
78,859
$939,000 30 Sep 2018
13F
Bank of New York Mellon Corp
13F
Company
0.28%
77,654
$925,000 30 Sep 2018
13F
DEUTSCHE BANK AG\
13F
Company
0.27%
75,056
$894,000 30 Sep 2018
13F
WEDGE CAPITAL MANAGEMENT L L P/NC
13F
Company
0.22%
61,389
$731,000 30 Sep 2018
13F
ALPS ADVISORS INC
13F
Company
0.21%
59,553
$709,000 30 Sep 2018
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.2%
57,081
$680,000 30 Sep 2018
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.2%
55,400
$660,000 30 Sep 2018
13F
PDT Partners, LLC
13F
Company
0.19%
51,849
$618,000 30 Sep 2018
13F
MORGAN STANLEY
13F
Company
0.17%
46,555
$554,000 30 Sep 2018
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.16%
43,549
$519,000 30 Sep 2018
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.14%
40,580
$483,000 30 Sep 2018
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.14%
38,714
$461,000 30 Sep 2018
13F
TEACHERS ADVISORS, LLC
13F
Company
0.13%
37,651
$448,000 30 Sep 2018
13F
LOS ANGELES CAPITAL MANAGEMENT LLC
13F
Company
0.13%
37,630
$448,000 30 Sep 2018
13F
VIRTUS ADVISERS, LLC
13F
Company
0.13%
35,601
$424,000 30 Sep 2018
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.1%
28,300
$337,000 30 Sep 2018
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.1%
27,100
$323,000 30 Sep 2018
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.09%
25,700
$306,000 30 Sep 2018
13F
RHUMBLINE ADVISERS
13F
Company
0.08%
21,411
$255,000 30 Sep 2018
13F
Claraphi Advisory Network, LLC
13F
Company
0.06%
18,000
$214,000 30 Sep 2018
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.06%
16,783
$200,000 30 Sep 2018
13F
Adalta Capital Management LLC
13F
Company
0.06%
15,925
$190,000 30 Sep 2018
13F
Kazazian Asset Management, LLC
13F
Company
0.05%
13,266
$158,000 30 Sep 2018
13F
MetLife Investment Management, LLC
13F
Company
0.05%
13,108
$156,116 30 Sep 2018
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.05%
12,705
$151,000 30 Sep 2018
13F
BARCLAYS PLC
13F
Company
0.04%
12,566
$150,000 30 Sep 2018
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.04%
12,500
$149,000 30 Sep 2018
13F
UBS Group AG
13F
Company
0.04%
12,038
$144,000 30 Sep 2018
13F

Institutional Holders of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) as of Q4 2018

As of 31 Dec 2018, Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,234,612 shares. The largest 10 holders included FMR LLC, Flagship Pioneering Inc., ARK Investment Management LLC, BlackRock Inc., Redmile Group, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Samsara BioCapital, LLC, Vanguard Group Inc, BAKER BROS. ADVISORS LP, and STATE STREET CORP. This page lists 67 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2018 vs Q3 2018 Across Filers

Q3 2018 holders
73
Q4 2018 holders
67
Holder diff
-6
Investor Q3 2018 Shares Q4 2018 Shares Share Diff Share Chg % Q3 2018 Value $ Q4 2018 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.